Muscimol inhibits plasma membrane rupture and ninjurin-1 oligomerization during pyroptosis

Andreas B den Hartigh1, Wendy P Loomis1, Marisa J Anderson1

  • 1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.

Communications Biology
|October 5, 2023
PubMed

Insights

Muscimol prevents cell lysis during pyroptosis, a cell death process linked to inflammation and disease. This study reveals muscimol blocks ninjurin-1 oligomerization, offering a new therapeutic target for inflammatory conditions.

Area of Science:

  • Cellular biology
  • Immunology
  • Pharmacology

Background:

  • Pyroptosis is an inflammatory cell death pathway crucial in disease, mediated by caspase-1 and gasdermin D.
  • Gasdermin D cleavage causes plasma membrane rupture, releasing inflammatory cellular contents.
  • Muscimol was previously identified as a molecule preventing pyroptotic cell lysis through an unknown mechanism.

Purpose of the Study:

  • To elucidate the mechanism by which muscimol prevents plasma membrane rupture during pyroptosis.
  • To investigate whether muscimol's effect on pyroptosis is mediated through GABAA receptors.
  • To explore the therapeutic potential of muscimol in a model of septic shock.

Main Methods:

  • Cell-based assays to assess pyroptosis and cell lysis.
  • Pharmacological inhibition and activation of GABAA receptors.
  • Structure-activity relationship studies of muscimol analogs.
  • In vivo studies using LPS-induced septic shock model.

Main Results:

  • Muscimol reversibly inhibited pyroptotic cell lysis without affecting upstream events.
  • Muscimol's protective effect was independent of GABAA receptor activity.
  • Muscimol was found to block ninjurin-1 oligomerization, a key step in membrane rupture.
  • Structure-activity relationship studies identified distinct molecular determinants for pyroptosis inhibition versus GABAA binding.
  • Muscimol administration reduced mortality in a mouse model of septic shock.

Conclusions:

  • Muscimol inhibits pyroptotic cell lysis by blocking ninjurin-1 oligomerization, independent of GABAA receptors.
  • Ninjurin-1 is a novel target for modulating pyroptosis-associated membrane rupture.
  • Pharmacological targeting of ninjurin-1 offers a potential therapeutic strategy for diseases involving pyroptosis.

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
690
Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
11.1K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K